Institute of Good Manufacturing Practices India
Global accredited training & certification provider
Approved by Quality Council Of India (QCI), Government of India
An ISO 9001:2008 Certified Organisation
Registered under The Societies Registration Act,1860 Government of India
Empanelled under Ministry of Horticulture and Food Processing, Government of Uttar Pradesh
International Register of Certificated Auditors (IRCA) accredited Lead Auditor (FSMS) course
Affiliated with Life Sciences Sector Skills Council (SSC) and Food Industry Sector Skills Council set up by National Skill Development Corporation (NSDC)
New Delhi | Noida | Hyderabad | Lucknow

Trusted by organizations & training participants in over 25 countries
Training | Certification | Education | Research

Changes being considered to Drugs and Cosmetic rules & GMP rules by CDSCO

India's central drug regulator is considering changes to the Drug and Cosmetics Rules like extending the validity of various licences and approvals in a move to improve ease of doing business for the industry. The government is planning a major overhaul of the country's drug policy, with moves that include scrapping the need to renew manufacturing licences and easing regulations to allow medical and drug research in India.

The central drug regulator is in the process of revisiting the 1945 Rules to see if the validity of various licences and approvals can be changed in order to remove the need for drug and cosmetic makers to periodically renew licences for the manufacture, sale and distribution of their products. The Central Drugs Standard Control Organisation (CDSCO) is also considering updating the rules to ensure that the Good Manufacturing Practices (GMP) are at par with the World Health Organisation GMP guidelines.

According to CDSCO, there should be assessment of compliance with the conditions of licences/approvals at least once in 10 years. CDSCO has already taken various steps to streamline import clearances and registration of drugs, medical devices and cosmetics, among other aspects. It has also initiated risk-based inspections of drug manufacturing facilities and has engaged in training state and central regulatory officials to improve the quality of the service they provide



Contact Us